International Stem Cell (ISCO) FCF Margin Growth (5y) (2015 - 2025)
International Stem Cell (ISCO) FCF Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | International Stem Cell | 3.76 Mn | 2.67 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,269.00 |
| Sep 30, 2025 | 2,078.00 |
| Jun 30, 2025 | -1,153.00 |
| Mar 31, 2025 | -67.00 |
| Dec 31, 2024 | 429.00 |
| Sep 30, 2024 | 2,049.00 |
| Jun 30, 2024 | 2,587.00 |
| Mar 31, 2024 | 883.00 |
| Dec 31, 2023 | 825.00 |
| Sep 30, 2023 | 2,015.00 |
| Jun 30, 2023 | 4,366.00 |
| Mar 31, 2023 | 1,362.00 |
| Dec 31, 2022 | 3,126.00 |
| Sep 30, 2022 | 2,377.00 |
| Jun 30, 2022 | 5,550.00 |
| Mar 31, 2022 | 2,774.00 |
| Dec 31, 2021 | 4,006.00 |
| Sep 30, 2021 | 1,136.00 |
| Jun 30, 2021 | 3,056.00 |
| Mar 31, 2021 | 10,186.00 |